Business Strategy

More Topics
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and IlluminaEyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina

BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending 16 February.

byMillie Nelson, Editor
Feb 18, 2025
|
1 Min Read
Steven fuller with a yellow background - Race in STEM founder and Director
ESG
Race in STEM: Countering the ugly truth of bias in life sciencesRace in STEM: Countering the ugly truth of bias in life sciences
byMillie Nelson
Feb 12, 2025
1 Min Read
Hot keys for business analysis and commercialization
Scaling/Commercialization
A clear commercialization strategy is imperative for success, says expertA clear commercialization strategy is imperative for success, says expert
byLisa Henderson
Jan 27, 2025
1 Min Read
the word deal written on blue blocks in white writing
Investment
JPM 2025: Gilead inks inflammatory deal with LEOJPM 2025: Gilead inks inflammatory deal with LEO
byMillie Nelson
Jan 20, 2025
1 Min Read
Novo Nordisk logo on a window
Business Strategy
Novo on the ‘ins and outs’ of its nucleic acid growthNovo on the ‘ins and outs’ of its nucleic acid growth
byDan Stanton
Jan 16, 2025
1 Min Read
dollar bills
Investment
JPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bnJPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bn
byMillie Nelson
Jan 15, 2025
1 Min Read
JPM written on wooden blocks in blue
Investment
JPM 2025: GSK shells out $1.15bn to buy oncology firm IDRx
JPM 2025: GSK shells out $1.15bn to buy oncology firm IDRx
Jan 14, 2025
|
1 Min Read
byMillie Nelson, Editor
Sean Knight, Senior Director, Business Development, Simtra BioPharma Solutions, discusses the company’s expansion plans.
Sponsored Content
Going to Market with Simtra BioPharma Solutions
Going to Market with Simtra BioPharma Solutions
Dec 19, 2024
|
3 Min View
byBIO-Europe 2024
Janet Hoogstraate, CEO, NorthX Biologics discusses the CDMOs capabilities and expertise.
Sponsored Content
NorthX Biologics is Beyond CDMO
NorthX Biologics is Beyond CDMO
Dec 18, 2024
|
4 Min View
byBIO-Europe 2024
Alex Fink, Senior Vice President, and Ed Salzman, Senior Strategic Advisor, both with Lumanity, discuss commercial readiness of biotechs
Sponsored Content
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Dec 18, 2024
|
9 Min View
byBIO-Europe 2024
Walter Boyle, Global Head of Axio, Cytel Inc., BIO-Europe 2024
Sponsored Content
Why are DMCs Important to Clinical Development?
Why are DMCs Important to Clinical Development?
Dec 17, 2024
|
4 Min View
byBIO-Europe 2024
@Informa BIO-Europe 2024, CEO of Cellevate interview
Sponsored Content
Scale Up and Boost Your Viral Vector Production
Scale Up and Boost Your Viral Vector Production
Dec 17, 2024
|
4 Min View
byBIO-Europe 2024
plan prepare perform
Investment
‘Luck only comes to the most prepared people,’ says AltruBio CEO
‘Luck only comes to the most prepared people,’ says AltruBio CEO
Dec 13, 2024
|
1 Min Read
byMillie Nelson, Editor
Data
Innovation
To protect the future of healthcare, we need to be data-driven
To protect the future of healthcare, we need to be data-driven
Dec 4, 2024
|
1 Min Read
byMillie Nelson, Editor
M&A note
Investment
Novartis chases muscular dystrophy treatment with Kate Tx buy
Novartis chases muscular dystrophy treatment with Kate Tx buy
Nov 27, 2024
|
1 Min Read
byMillie Nelson, Editor
Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Nov 22, 2024
|
1 Min Read
byMillie Nelson, Editor
Seed Funding
Europe’s aversity to risk is why the US is ahead, say experts
Europe’s aversity to risk is why the US is ahead
Nov 5, 2024
|
1 Min Read
byMillie Nelson, Editor
Picture with women's health written on a card in pink
Investment
Call for specific female health funding to tackle biotech finance gender gap
Call for specific female health funding to tackle biotech finance gender gap
Oct 30, 2024
|
1 Min Read
byMillie Nelson, Editor
Webinar: Cracking the code - Mastering biopharma launches in Europe
Business Strategy
Cracking the code: Mastering biopharma launches in Europe
Cracking the code: Mastering biopharma launches in Europe
Oct 24, 2024
Business Strategy
Build trust by making healthcare fairer and more equitable, say experts
Build trust by making healthcare fairer and more equitable, say experts
Oct 14, 2024
|
1 Min Read
byMillie Nelson, Editor
Green leaf with sustainability symbol
Business Strategy
The sustainability series: Reflect, rethink, and reform
The sustainability series: Reflect, rethink, and reform
Oct 11, 2024
|
1 Min Read
byMillie Nelson, Editor
Overhead view of business people working and funding
Investment
$325 million Series C funding in its Arsenal (Biosciences)
$325 million Series C funding in its Arsenal (Biosciences)
Sep 25, 2024
|
1 Min Read
byMillie Nelson, Editor
Christmas present
Partnering
RayzeBio: A Christmas to remember
RayzeBio: A Christmas to remember
Sep 25, 2024
|
1 Min Read
byMillie Nelson, Editor
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
Sep 21, 2024
|
1 Min Read
photo of a hand holding a globe representing the environment.
Business Strategy
From aspiration to action: navigating sustainability in biopharma
Navigating sustainability in biopharma
Sep 19, 2024
|
1 Min Read
different coloured smoke
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”
Building successful teams in biotech
May 7, 2024
|
1 Min Read
byMillie Nelson, Editor
CEO of Poseida, Kristin Yarema
Business Strategy
Poseida: New CEO, same passion for allogeneic therapies
Poseida: New CEO, same passion for allogeneic therapies
Feb 26, 2024
|
1 Min Read
byMillie Nelson, Editor
Sand timer
Business Strategy
Testing times: MilliporeSigma talks CDMO competition
Testing times: MilliporeSigma talks CDMO competition
Oct 11, 2023
|
1 Min Read
byMillie Nelson, Editor
Broken heart
Partnering
It’s not me, it’s you! Experts on when you should dump your CDMO
Experts on when you should dump your CDMO
Sep 22, 2023
|
1 Min Read
byMillie Nelson, Editor
Clinical Trials Word Cloud illustration
Innovation
Clinical trial innovation at BIO-Europe Spring 2023
Clinical trial innovation at BIO-Europe Spring 2023
Sep 21, 2023
|
1 Min Read
Note with politics written on it
Business Strategy
Patient access is political, say CGT experts
Patient access is political, say CGT experts
Jan 9, 2023
|
1 Min Read
byMillie Nelson, Editor

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Sponsored Content
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech

Latest

Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated